A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice

Molecular Carcinogenesis

Volumn 51, Issue 11, 2012, Pages 869-880

  Park, Heesook ^a   Kim, Minhee ^a   Kwon, Gyoo Taik ^a   Lim, Do Young ^a   Yu, Rina ^b   Sung, Mi Kyung ^c   Lee, Ki Won ^d   Daily III, James W ^e   Park, Jung Han Yoon ^a,f  

^a Hallym University   (South Korea)

^b University of Ulsan   (South Korea)

^c Sookmyung Women's University   (South Korea)

^d Seoul National University   (South Korea)

^e Daily Manufacturing Inc   (United States)

^f Kyungpook National University   (South Korea)

Author keywords

Angiogenesis; Colon cancer; High fat diet; Inflammation; Metastasis

Indexed keywords

CD31 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; I KAPPA B ALPHA; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN P53; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; SYNAPTOPHYSIN; SYNAPTOTAGMIN I; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SIZE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; EPIDIDYMIS FAT; HUMAN; HUMAN CELL; LIPID DIET; LUNG METASTASIS; LUNG NODULE; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; TISSUE LEVEL; WEIGHT GAIN;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; CYTOKINES; DIET, HIGH-FAT; LEUKOCYTES; LUNG; LUNG NEOPLASMS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; OBESITY;

MUS;

EID: 84863709139     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20856     Document Type: Article

References (59)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Tammariello AE, Milner JA. Mouse models for unraveling the importance of diet in colon cancer prevention. J Nutr Biochem 2010; 21: 77-88.
3. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006; 12: 62-66.
4. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-A growing challenge. N Engl J Med 2007; 356: 213-215.
5. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006; 55: 285-291.
6. IARC. Weight control and physical activity. Lyon: International Agency for Research on Cancer; 2002. pp. 1-315.
7. Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr 1997; 66: 1564S-1571S.
8. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
9. Prizment AE, Flood A, Anderson KE, Folsom AR. Survival of women with colon cancer in relation to precancer anthropometric characteristics: The Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2010; 19: 2229-2237.
10. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity 2007; 15: 798-808.
11. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 2000; 24: 639-646.
12. Campos FG, Logullo Waitzberg AG, Kiss DR, Waitzberg DL, Habr-Gama A, Gama-Rodrigues J. Diet and colorectal cancer: Current evidence for etiology and prevention. Nutr Hosp 2005; 20: 18-25.
13. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-1788.
14. Pischon T, Nothlings U, Boeing H. Obesity and cancer. Proc Nutr Soc 2008; 67: 128-145.
15. Johnson IT, Lund EK. Review article: Nutrition, obesity and colorectal cancer. Aliment Pharmacol Ther 2007; 26: 161-181.
16. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: Epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006; 17: 145-156.
17. Olson LK, Tan Y, Zhao Y, Aupperlee MD, Haslam SZ. Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness. Int J Obes (Lond) 2010; 34: 1415-1426.
18. Fearnside JF, Dumas ME, Rothwell A, et al. Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS ONE 2008; 3: e1668.
19. Sauter BV, Martinet O, Zhang WJ, Mandeli J, Woo SL. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci USA 2000; 97: 4802-4807.
20. Welch DR, Neri A, Nicolson GL. Comparison of 'spontaneous' and 'experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis 1983; 3: 65-80.
21. Rose DP, Connolly JM. Influence of dietary fat intake on local recurrence and progression of metastases arising from MDA-MB-435 human breast cancer cells in nude mice after excision of the primary tumor. Nutr Cancer 1992; 18: 113-122.
22. Kim EJ, Shin M, Park H, et al. Oral administration of 3, 3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. J Nutr 2009; 139: 2373-2379.
23. Cho HJ, Kim WK, Kim EJ, et al. Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol 2003; 284: G996-G1005.
24. Yu R, Kim CS, Kwon BS, Kawada T. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity 2006; 14: 1353-1362.
25. Masson VV, Devy L, Grignet-Debrus C, et al. Mouse aortic ring assay: A new approach of the molecular genetics of angiogenesis. Bioll Proced Online 2002; 4: 24-31.
26. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70, 000 events. Cancer Epidemiol Biomarkers Prev 2007; 16: 2533-2547.
27. Dai Z, Xu YC, Niu L. Obesity and colorectal cancer risk: A meta-analysis of cohort studies. World J Gastroenterol 2007; 13: 4199-4206.
28. Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: Findings from 56 observational studies. Obes Rev 2010; 11: 19-30.
29. Chapkin RS, McMurray DN, Lupton JR. Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 2007; 23: 48-54.
30. Reddy BS, Burill C, Rigotty J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991; 51: 487-491.
31. Kromhout D. The importance of N-6 and N-3 fatty acids in carcinogenesis. Med Oncol Tumor Pharmacother 1990; 7: 173-176.
32. Bartoli R, Fernandez-Banares F, Navarro E, et al. Effect of olive oil on early and late events of colon carcinogenesis in rats: Modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 2000; 46: 191-199.
33. Davidson LA, Nguyen DV, Hokanson RM, et al. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 2004; 64: 6797-6804.
34. Williams CD, Satia JA, Adair LS, et al. Associations of red meat, fat, and protein intake with distal colorectal cancer risk. Nutr Cancer 2010; 62: 701-709.
35. Liu L, Zhuang W, Wang RQ, et al. Is dietary fat associated with the risk of colorectal cancer? A meta-analysis of 13 prospective cohort studies. Eur J Nutr 2011; 50: 173-184.
36. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006; 1: 119-150.
37. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
38. Darnell JE, Jr. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002; 2: 740-749.
39. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-342.
40. Nam SY, Lee EJ, Kim KR, et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 1997; 21: 355-359.
41. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-732.
42. Semenza GL. Development of novel therapeutic strategies that target HIF-1. Expert Opin Ther Targets 2006; 10: 267-280.
43. Baba Y, Nosho K, Shima K, et al. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol 2010; 176: 2292-2301.
44. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275.
45. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 2005: re 12.
46. Vona-Davis L, Rose DP. Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev 2009; 20: 193-201.
47. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011-1027.
48. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29: 15-18.
49. Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004; 3: 391-400.
50. Considine RV. Regulation of leptin production. Rev Endocr Metab Disord 2001; 2: 357-363.
51. Cong L, Chen K, Li J, et al. Regulation of adiponectin and leptin secretion and expression by insulin through a PI3K-PDE3B dependent mechanism in rat primary adipocytes. Biochem J 2007; 403: 519-525.
52. Buyse M, Viengchareun S, Bado A, Lombes M. Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes. FASEB J 2001; 15: 1357-1366.
53. Stattin P, Lukanova A, Biessy C, et al. Obesity and colon cancer: Does leptin provide a link? Int J Cancer 2004; 109: 149-152.
54. Stattin P, Palmqvist R, Soderberg S, et al. Plasma leptin and colorectal cancer risk: A prospective study in Northern Sweden. Oncol Rep 2003; 10: 2015-2021.
55. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683-1686.
56. Birmingham JM, Busik JV, Hansen-Smith FM, Fenton JI. Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis 2009; 30: 690-697.
57. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001; 121: 79-90.
58. Jaffe T, Schwartz B. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 2008; 123: 2543-2556.
59. Endo H, Hosono K, Uchiyama T, et al. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 2011.